Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Science Supporting Ephedra Ban Fails FDA’s Own Standard – Nutraceutical

This article was originally published in The Tan Sheet

Executive Summary

Scientific evidence used by FDA to support its outright ban of ephedra would not meet the agency's "own criteria for competent scientific evidence," low-dose ephedra marketer Nutraceutical asserts
Advertisement

Related Content

GMP Cost Impact, Ephedra Suits Loom Over Supplement Industry – Israelsen
GMP Cost Impact, Ephedra Suits Loom Over Supplement Industry – Israelsen
GMP Cost Impact, Ephedra Suits Loom Over Supplement Industry – Israelsen
“No Evidence” Exists That Ephedra Ban Shifted Burden Of Proof, Agency Says
“No Evidence” Exists That Ephedra Ban Shifted Burden Of Proof, Agency Says
“No Evidence” Exists That Ephedra Ban Shifted Burden Of Proof, Agency Says
FDA Appeals Utah Ephedra Court Ruling, Defends Use Of Risk/Benefit Analysis
Utah Court Overturns Ephedra Ban For Low-Dose Products
Utah Court Overturns Ephedra Ban For Low-Dose Products

Topics

Advertisement
UsernamePublicRestriction

Register

PS098722

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel